{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-023293","form_type":"8-K","ticker":"STEX","cik":"0001530766","company_name":"Streamex Corp.","filed_at":"2024-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.863915+00:00","generated_at":"2026-06-01T05:17:20.924965+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BioSig Technologies appoints Ferdinand Groenewald as interim CFO after Hrkac resignation","bullets":["Frederick Hrkac resigned as acting CFO and principal accounting officer effective June 5, 2024.","Ferdinand Groenewald appointed interim CFO, principal accounting officer, VP finance under consulting agreement.","Groenewald compensation: $15,000 per month plus expense reimbursement; currently VP Finance at Alaunos Therapeutics.","Groenewald previously served as CFO of Muscle Maker, Inc. and director of HeartCore and SYLA Technologies."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-023293","json":"https://secwatch.observer/filing/0001493152-24-023293.json","markdown":"https://secwatch.observer/filing/0001493152-24-023293.md","text":"https://secwatch.observer/filing/0001493152-24-023293.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224023293/0001493152-24-023293-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224023293/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:17:20.924965+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5fe4ef9550","claim":"Frederick D. Hrkac resigned as acting chief financial officer and principal accounting officer at Streamex Corp..","evidence_excerpt":"On June 5, 2024, Mr. Frederick D. Hrkac resigned as acting chief financial officer and principal accounting officer of BioSig Technologies, Inc. (“BioSig” or “Company”) effective as of the same date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224023293/0001493152-24-023293-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"acting chief financial officer and principal accounting officer"}],"fact_type":"executive_change"},{"claim_id":"9fc2187fc4","claim":"Ferdinand Groenewald was appointed as interim chief financial officer, principal accounting officer and vice president of finance at Streamex Corp..","evidence_excerpt":"Mr. Groenewald will serve as the Company’s interim chief financial officer, principal accounting officer and vice president of finance.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224023293/0001493152-24-023293-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim chief financial officer, principal accounting officer and vice president of finance"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}